Generic placeholder image

Current Organic Chemistry

Editor-in-Chief

ISSN (Print): 1385-2728
ISSN (Online): 1875-5348

Dehydrogenases/Reductases for the Synthesis of Chiral Pharmaceutical Intermediates

Author(s): Yan Huang, Nan Liu, Xuri Wu and Yijun Chen

Volume 14, Issue 14, 2010

Page: [1447 - 1460] Pages: 14

DOI: 10.2174/138527210791616795

Price: $65

Abstract

The increasing trend of chiral drugs in the pharmaceutical industry has promoted greatly on the development of numerous biocatalytic routes in combination with chemical methods. Because the resulting chiral alcohols are particularly valuable intermediates and precursors for the synthesis of chiral drugs, dehydrogenases and reductases have been extensively used in the synthesis of chiral compounds from ketone substrates with high regio- and stereo-selectivities. In this review, biocatalytic processes carried out by dehydrogenases and reductases are described for the synthesis of chiral intermediates for a wide variety of pharmaceuticals, including antidepressants, anti-anxieties, anti-asthmatics, anti-hypertensives, cholesterol-lowering agents, NK1 antagonists, ACE inhibitors and β- Lactamase inhibitors.

Keywords: Biocatalysis, Dehydrogenases, Reductases, Chiral intermediates, Stereoselectivity, Cofactor regeneration


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy